Atossa Therapeutics Responds to PTAB Ruling on U.S. Patent No. 11,572,334 and Announces the Issuance of U.S. Patent No. 12,201,591
Atossa is also announcing the issuance of a new patent on January 21, 2025, U.S. Patent No. 12,201,591, entitled, “Sustained Release Compositions of Endoxifen.” The 31 claims of this new patent are ...
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...
United Parcel Service (UPS) Q4 2024 Earnings Call Transcript
I would like to welcome everyone to the UPS fourth quarter 2024 earnings conference call. [Operator instructions] It is now ...
Markets regulatory Sebi cancels registration of 4 stock brokers; Here's why
Following the proper procedures outlined in the Intermediaries Regulations, 2008, SEBI has cancelled the registration ...